Table 1.
Pancreas cancer cell lines characteristics and their dasatinib IC50
Cell Line | Derivation | Genetic background | IC50 (nmol/L) |
---|---|---|---|
MiaPaca2 | Primary | Mutant K-ras, mutant p53, wt smad4 | 51.28 |
PANC1 | Primary | Mutant K-ras, mutant p53, wt smad4 | 45.68 |
AsPC1 | Metastasis (ascites) | Mutant K-ras, wt p53, wt smad4 | 44.97 |
CEPAC1 | Metastasis (liver) | Mutant K-ras, wt p53, mutant smad4 | 24.99 |
Capan1 | Metastasis (liver) | Mutant K-ras, ND p53, mutant smad4 | 9.604 |
SW1990 | Metastasis (spleen) | Mutant K-ras, wt p53, ND smad4 | 5.106 |
Capan2 | Primary | Mutant K-ras, wt p53, wt smad4 | 4.872 |
HPAC | Primary | Mutant K-ras, wt p53, wt smad4 | 2.791 |
BxPC3 | Primary | Wt K-ras, mutant p53, mutant smad4 | 2.809 |
WT: wild type; ND: not determined